View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EXL unveils new agentic AI solutions to accelerate enterprise transfor...

EXL unveils new agentic AI solutions to accelerate enterprise transformation across the full AI value chain Expanded portfolio integrates agent development, governance, decision intelligence and domain workflows to help enterprises scale AI responsibly and deliver measurable business outcomes NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) --  [NASDAQ: EXLS], a global data and AI company, today launched a series of new agentic AI solutions, expanding its portfolio to help enterprises move from AI experimentation to large-scale, measurable impact. This initiative includes: Enhancements to our...

 PRESS RELEASE

electroCore to Participate at the 38th Annual Roth Conference

electroCore to Participate at the 38th Annual Roth Conference ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual Roth Conference March 22-24 at the Ritz-Carlton in Laguna Niguel, California. Joshua Lev, Chief Financial Officer, will host one-on-one meetings at the conference. Investors attending this event who are interested in scheduling a meeting with management can do so by contacting their respective Roth representative, or by emailing ...

 PRESS RELEASE

electroCore to Announce Fourth Quarter and Full Year Ended December 31...

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026. Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the d...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 7, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to one new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as...

 PRESS RELEASE

Hooker Furnishings Declares Quarterly Dividend

Hooker Furnishings Declares Quarterly Dividend MARTINSVILLE, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on March 5, 2026, its board of directors declared a quarterly cash dividend of $0.115 per share, payable on March 31, 2026, to shareholders of record on March 16, 2026. Hooker Furnishings Corporation, in its 102nd year of business, is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home décor for the residential, hospitali...

 PRESS RELEASE

Ring Energy Releases Fourth Quarter and Full Year 2025 Results, Year-E...

Ring Energy Releases Fourth Quarter and Full Year 2025 Results, Year-End 2025 Proved Reserves, and Provides 2026 Guidance THE WOODLANDS, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported operational and financial results for the fourth quarter and full year 2025, year-end 2025 proved reserves and provided 2026 operational and financial guidance. Fourth Quarter 2025 Highlights Sold 13,124 barrels of oil per day (“Bo/d”), near the mid-point of guidance and 20,508 barrels of oil equivalent per day (“Boe/d”) which was a...

 PRESS RELEASE

EXL named a Leader in Everest Group Customer Experience Services in In...

EXL named a Leader in Everest Group Customer Experience Services in Insurance Operations PEAK Matrix® Assessment 2025 NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS], a global data and AI company, has been named a Leader in the Everest Group Customer Experience (CX) Services in Insurance Operations PEAK Matrix® Assessment 2025. The Everest Group report examined 21 leading CX services in insurance operations providers, including Property and Casualty (P&C) and Life and Annuities (L&A) services. The assessment delivers an objective, comparative lens on provider innovation and ...

 PRESS RELEASE

Fulcrum Therapeutics to Participate in the Leerink Partners Global Hea...

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that company management will present at the Leerink Partners Global Healthcare Conference in Miami, FL on Tuesday, March 10, 2025 at 1:00 p.m. ET. The webcast of the presentation will be accessible or by visiting the "Eve...

 PRESS RELEASE

Vista Gold Corp. Announces Pricing of US$39.0 million Public Offering ...

Vista Gold Corp. Announces Pricing of US$39.0 million Public Offering of Common Shares DENVER, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) is pleased to announce the pricing of its previously announced underwritten public offering of 15,600,000 of its common shares at a price to the public of US$2.50 per share. The total gross proceeds to Vista are expected to be US$39.0 million, before deducting underwriting discounts and commission and other offering expenses payable by Vista. The offering is expected to close on March 9, ...

 PRESS RELEASE

Vista Gold Corp. Announces Proposed Public Offering of Common Shares

Vista Gold Corp. Announces Proposed Public Offering of Common Shares DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) is pleased to announce that it has commenced an underwritten public offering of US$30.0 million of its common shares. All common shares are being offered by Vista. The Company expects to grant the underwriters a 30-day option to purchase up to an additional US$4.5 million of its common shares to cover over-allotments, if any. The proposed offering is subject to market conditions and other factors, and there...

Moody's Ratings affirms Aa1 rating to preferred shares issued by Black...

Moody's Ratings (Moody's) has affirmed the long-term Aa1 rating to Variable Rate Demand Preferred Shares (VRDP Shares) issued by BlackRock MuniYield Quality Fund III, Inc. (NYSE: MYI) following the reorganizations of two other BlackRock closed-end funds into the fund. The outlook is stable. Effect...

 PRESS RELEASE

Dorchester Minerals, L.P. Announces 2025 Results

Dorchester Minerals, L.P. Announces 2025 Results DALLAS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the year ended December 31, 2025 of $57,352,000 or $1.16 per common unit. A comparison of the Partnership’s consolidated results for the twelve month periods ended December 31, 2025 and 2024 are set forth below:  Twelve Months Ended December 31, 2025 2024Operating Revenues$152,832,000 $161,523,000Net Income$57,352,000 $92,449,000Net Income Per Common Unit$1.16 $2.13 The Partnership’s indepen...

 PRESS RELEASE

EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guid...

EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance 2025 Fourth Quarter Revenue of $542.6 Million, up 12.7% year-over-yearQ4 Diluted EPS (GAAP) of $0.38, up 21.8% from $0.31 in Q4 of 2024Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $0.50, up 15.0% from $0.44 in Q4 of 2024 2025 Revenue of $2.09 Billion, up 13.6% year-over-year2025 Diluted EPS (GAAP) of $1.54, up 28.0% from $1.21 in 20242025 Adjusted Diluted EPS (Non-GAAP) (1) of $1.95, up 18.0% from $1.65 in 2024 NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and A...

 PRESS RELEASE

EXL announces speaker roster for AI in Action Americas virtual event –...

EXL announces speaker roster for AI in Action Americas virtual event – accelerating enterprise AI from pilot to impact Americas virtual event to take place March 11, 2026—featuring leaders from Google, Databricks, CNBC, Wolters Kluwer and Transamerica NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) --  [NASDAQ: EXLS], a global data and AI company, announced the speaker lineup for its upcoming AI in Action virtual event on March 11 from 10-11 a.m. EDT. The annual forum convenes prominent business and technology leaders to reveal the latest innovations making agentic AI a reality for modern en...

 PRESS RELEASE

GCM Grosvenor Raises $625 Million Structured Solution to Invest in Cre...

GCM Grosvenor Raises $625 Million Structured Solution to Invest in Credit CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a leading global alternative asset management solutions provider, announced today the second close of its structured alternatives investment solution, bringing total capital commitments to $625 million. This vehicle offers investors an opportunity to access a diversified portfolio of credit secondaries investments, with flexibility to participate through equity or debt in a rated structure. With nearly 40 years of experience, GCM Grosvenor’s c...

 PRESS RELEASE

Fulcrum Therapeutics Announces Recent Business Highlights and Financia...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025 ― Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― 20 mg cohort demonstrated rapid and robust fetal hemoglobin (HbF) induction, with mean absolute HbF increasing by 12.2% from a baseline of 7.1% to 19.3% at Week 12, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlusive crisis (VOC) reduction ― ― Fulcrum plans to initiate a potential registration-ena...

 PRESS RELEASE

Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg...

Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease ― Mean absolute fetal hemoglobin (HbF) increased by 12.2% (from 7.1% to 19.3%) at Week 12 (n=12), representing a rapid, robust, and clinically relevant response, with progression toward pan-cellular HbF induction as F-cells increased from 31% to 63% ― ― 7 of 12 patients (58%) achieved absolute HbF levels ≥20%; all patients achieved at least a 6.5% absolute increase in HbF ― ― Improvements in markers of hemolysis, improved erythropoiesis, and ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch